Bluefish Pharmaceuticals AB

Founded in Sweden, with its long tradition of industrial entrepreneurship, Bluefish Pharmaceuticals is one of the most progressive generics pharmaceuticals companies. Since its inception in 2005 Bluefish has acquired the know-how and developed a platform to operate in all the major steps of the value chain of the generic pharmaceuticals business. Driven by our vision of offering high quality pharmaceuticals at prices affordable to all we have worked out new and more cost efficient ways of operating, in areas ranging from product development, quality assurance, pharmacovigilance, IP and supply chain, as well as marketing and sales.

Bluefish has created a strong platform and has a proven business model that is operating on 20 developed generics markets in Europe. Thanks to our experience, flexibility and cost centric mindset, we have developed a lean organization, able to quickly launch new products in markets and rapidly react by adapting to market changes. Bluefish is currently expanding outside Europe and is focused on becoming a global player, bringing the benefits of our vision for medicines to more patients and healthcare systems throughout the world.

Bluefish offers a product portfolio consisting of a broad range of high quality generics for all major therapeutic areas. The company currently has 80 products and a long-term strategy of expanding the product portfolio further, focusing not only on off-patent blockbusters but also offering a broader range of niche products in more narrow disease areas.

Bluefish Pharmaceuticals AB
+46 8 5191 1600
+46 8 5191 1690